{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T04:53:03Z","timestamp":1766724783239,"version":"3.48.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.7759\/cureus.100089","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T03:42:51Z","timestamp":1766720571000},"source":"Crossref","is-referenced-by-count":0,"title":["Safety and Tolerance of a Novel MMR (Measles, Mumps, and Rubella) Vaccine in Indian Children: A Real-World Evidence Study"],"prefix":"10.7759","author":[{"given":"Jagannatha  R","family":"Pula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakeshkumar  M","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay  V","family":"Mankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapan","family":"Vinayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santanu","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabyasachi","family":"Bhattacharjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyush","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonam","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trayambak","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World Health Organization. Measles cases surge worldwide, infecting 10.3 million people in 2023. (2024). Accessed: 2025: https:\/\/www.who.int\/news\/item\/14-11-2024-measles-cases-surge-worldwide--infecting-10.3-million-people-in-2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31463-0","article-title":"Measles","volume":"390","author":"Moss WJ","year":"2017","unstructured":"Moss WJ. Measles. Lancet. 2017, 390:2490-502. 10.1016\/S0140-6736(17)31463-0","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/path.4467","article-title":"Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma","volume":"235","author":"Underwood TJ","year":"2015","unstructured":"Underwood TJ, Hayden AL, Derouet M, et al.. Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma. J Pathol. 2015, 235:466-77. 10.1002\/path.4467","journal-title":"J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15897-2","article-title":"Rubella","volume":"363","author":"Banatvala JE","year":"2004","unstructured":"Banatvala JE, Brown DW. Rubella. Lancet. 2004, 363:1127-37. 10.1016\/S0140-6736(04)15897-2","journal-title":"Lancet"},{"key":"ref5","unstructured":"Ministry of Health and Family Welfare. Update on vaccination campaign for children. (2025). Accessed: 2025: https:\/\/www.mohfw.gov.in\/?q=en\/pressrelease-286."},{"key":"ref6","article-title":"Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): recommended immunization schedule (2023) and update on immunization for children aged 0 through 18 years","author":"Rao IS","year":"2024","unstructured":"Rao IS, Kasi SG, Dhir SK, et al.. Indian Academy of Pediatrics (IAP) Advisory Committee on Vaccines and Immunization Practices (ACVIP): recommended immunization schedule (2023) and update on immunization for children aged 0 through 18 years. Indian Ped. 2024,","journal-title":"Indian Ped"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2302685","article-title":"A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine","volume":"20","author":"Shah N","year":"2024","unstructured":"Shah N, Ghosh A, Kumar K, Dutta T, Mahajan M. A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine. Hum Vaccin Immunother. 2024, 20:2302685. 10.1080\/21645515.2024.2302685","journal-title":"Hum Vaccin Immunother"},{"key":"ref8","article-title":"Summary of Product Characteristics as per Annexure C Measles, Mumps and Rubella Vaccine (Live) I.P. (Freeze Dried) ZyVac\u00ae MMR","year":"2024","unstructured":"Summary of Product Characteristics as per Annexure C Measles, Mumps and Rubella Vaccine (Live) I.P. (Freeze Dried) ZyVac\u00ae MMR. Zydus Lifesciences Limited, Ahmedabad, India; 2024."},{"key":"ref9","article-title":"World Health Organization. Mumps virus vaccines: WHO position paper","year":"2024","unstructured":"Mumps Virus Vaccines. WHO Position Paper, March 2024. World Health Organization, Geneva, Switzerland; 2024. https:\/\/www.who.int\/publications\/i\/item\/who-wer-9911-115-133."},{"key":"ref10","article-title":"Immunogenicity and safety of a novel MMR vaccine (live) (freeze-dried): results of a phase II clinical trial","volume":"12","author":"Joshi R","year":"2018","unstructured":"Joshi R, Hanumante N, Nayak U, Agarkhedkar S, Thakkar P, Sanmukhani J, Mittal R. Immunogenicity and safety of a novel MMR vaccine (live) (freeze-dried): results of a phase II clinical trial. J Clin Diagn Res. 2018, 12:SC09-13.","journal-title":"J Clin Diagn Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1302629","article-title":"Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27\/3 rubella strain: results of a randomized, comparative, active controlled phase III clinical trial","volume":"13","author":"Sood A","year":"2017","unstructured":"Sood A, Mitra M, Joshi HA, et al.. Immunogenicity and safety of a novel MMR vaccine (live, freeze-dried) containing the Edmonston-Zagreb measles strain, the Hoshino mumps strain, and the RA 27\/3 rubella strain: results of a randomized, comparative, active controlled phase III clinical trial. Hum Vaccin Immunother. 2017, 13:1523-30. 10.1080\/21645515.2017.1302629","journal-title":"Hum Vaccin Immunother"},{"key":"ref12","unstructured":"Centers for Disease Control and Prevention Vaccine Safety. MMR (measles, mumps, rubella) vaccine safety. (2024). Accessed: 2025: https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/mmr.html."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004407.pub5","article-title":"Vaccines for measles, mumps, rubella, and varicella in children","volume":"11","author":"Di Pietrantonj C","year":"2021","unstructured":"Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V. Vaccines for measles, mumps, rubella, and varicella in children. Cochrane Database Syst Rev. 2021, 11:CD004407. 10.1002\/14651858.CD004407.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref14","unstructured":"World Health Organization. Measles. (2025). Accessed: 2025: https:\/\/www.who.int\/health-topics\/measles."},{"key":"ref15","article-title":"Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)--United States, 1991-2001","volume":"52","author":"Zhou W","year":"2003","unstructured":"Zhou W, Pool V, Iskander JK, et al.. Surveillance for safety after immunization: vaccine adverse event reporting system (VAERS)--United States, 1991-2001. MMWR Surveill Summ. 2003, 52:1-24.","journal-title":"MMWR Surveill Summ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaj2345","article-title":"The broad socioeconomic benefits of vaccination","volume":"10","author":"Bloom DE","year":"2018","unstructured":"Bloom DE, Fan VY, Sevilla JP. The broad socioeconomic benefits of vaccination. Sci Transl Med. 2018, 10:10.1126\/scitranslmed.aaj2345","journal-title":"Sci Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald NE","year":"2015","unstructured":"MacDonald NE. Vaccine hesitancy: definition, scope and determinants. Vaccine. 2015, 33:4161-4. 10.1016\/j.vaccine.2015.04.036","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7345a3","article-title":"Pediatric rash illness outbreak with initial positive measles immunoglobulin m antibody test results - American Samoa, March-July 2023","volume":"73","author":"Stefanos R","year":"2024","unstructured":"Stefanos R, Schatzman S, Wakeman B, et al.. Pediatric rash illness outbreak with initial positive measles immunoglobulin m antibody test results - American Samoa, March-July 2023. MMWR Morb Mortal Wkly Rep. 2024, 73:1030-5. 10.15585\/mmwr.mm7345a3","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445163-safety-and-tolerance-of-a-novel-mmr-measles-mumps-and-rubella-vaccine-in-indian-children-a-real-world-evidence-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T03:42:53Z","timestamp":1766720573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445163-safety-and-tolerance-of-a-novel-mmr-measles-mumps-and-rubella-vaccine-in-indian-children-a-real-world-evidence-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.100089","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}